Multidrug-resistant breast cancer: current perspectives

Código QR

Multidrug-resistant breast cancer: current perspectives

Heather L Martin,1 Laura Smith,2 Darren C Tomlinson11BioScreening Technology Group, Leeds Institutes of Molecular Medicine, University of Leeds, Leeds, UK; 2Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UKAbstract: Breast cancer is the most common cancer in women worldwide, a...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Martin HL, Smith L, Tomlinson DC
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2014
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/cf782eab03c54343a1797a388524479b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Exercise after breast cancer treatment: current perspectives
por: Dieli-Conwright CM, et al.
Publicado: (2015)

Preserving fertility in patients undergoing treatment for breast cancer: current perspectives
por: Moffat R, et al.
Publicado: (2014)

Hypofractionated whole breast radiotherapy: current perspectives
por: Koulis TA, et al.
Publicado: (2015)

Current strategies for the prevention of breast cancer
por: Advani P, et al.
Publicado: (2014)

Current perspectives on CHEK2 mutations in breast cancer
por: Apostolou P, et al.
Publicado: (2017)

Triple negative breast cancer: an Indian perspective
por: Akhtar M, et al.
Publicado: (2015)

Immunotherapy in breast cancer: A clinician's perspective
por: Sibapriya Chaudhuri, et al.
Publicado: (2021)

Targeting PD-1/PD-L1 in lung cancer: current perspectives
por: González-Cao M, et al.
Publicado: (2015)

Current and emerging quantitative magnetic resonance imaging methods for assessing and predicting the response of breast cancer to neoadjuvant therapy
por: Abramson RG, et al.
Publicado: (2012)

Breast reconstruction: current and future options
por: Paul Jr H, et al.
Publicado: (2011)

Breast cancer dormancy: need for clinically relevant models to address current gaps in knowledge
por: Grace G. Bushnell, et al.
Publicado: (2021)

Low NCOR2 levels in multiple myeloma patients drive multidrug resistance via MYC upregulation
por: Tomoaki Mori, et al.
Publicado: (2021)

A common goal to CARE: Cancer Advocates, Researchers, and Clinicians Explore current treatments and clinical trials for breast cancer brain metastases
por: Natalie S. Joe, et al.
Publicado: (2021)

Intraoperative radiation therapy for breast cancer patients: current perspectives
por: Dutta SW, et al.
Publicado: (2017)

Immunohistochemical analysis of aldehyde dehydrogenase isoforms and their association with estrogen-receptor status and disease progression in breast cancer
por: Opdenaker LM, et al.
Publicado: (2014)

MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit
por: Sanne Løkkegaard, et al.
Publicado: (2021)

Inherited predisposition to breast cancer in the Carolina Breast Cancer Study
por: Tom Walsh, et al.
Publicado: (2021)

Characterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analytics
por: Allen Li, et al.
Publicado: (2021)

Current gene panels account for nearly all homologous recombination repair-associated multiple-case breast cancer families
por: Thibaut S. Matis, et al.
Publicado: (2021)

Identification of genes involved in breast cancer and breast cancer stem cells
por: Apostolou P, et al.
Publicado: (2015)

Neurological Adverse Events Induced by Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Current Perspectives and New Development
por: Ke Cheng, et al.
Publicado: (2021)

Dormancy in breast cancer
por: Banys M, et al.
Publicado: (2012)

The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk
por: Thomas P. Slavin, et al.
Publicado: (2017)

Lapatinib in patients with metastatic breast cancer following initial treatment with trastuzumab: an economic analysis from the Brazilian public health care perspective
por: Machado M, et al.
Publicado: (2012)

Intensity modulated radiation therapy for breast cancer: current perspectives
por: Buwenge M, et al.
Publicado: (2017)

Tumor-associated autoantibodies from mouse breast cancer models are found in serum of breast cancer patients
por: Sasha E. Stanton, et al.
Publicado: (2021)

An alternative model for (breast) cancer predisposition
por: Erik Teugels, et al.
Publicado: (2017)

Optical imaging for breast cancer prescreening
por: Godavarty A, et al.
Publicado: (2015)

Role of the WASP and WAVE family proteins in breast cancer invasion and metastasis
por: Frugtniet B, et al.
Publicado: (2015)

Can population breast screening programs be leveraged to reduce the burden of breast cancer?
por: Nehmat Houssami
Publicado: (2021)

Establishment and characterization of immortalized human breast cancer cell lines from breast cancer patient-derived xenografts (PDX)
por: Yongxian Zhuang, et al.
Publicado: (2021)

Dynamic contrast-enhanced breast MRI features correlate with invasive breast cancer angiogenesis
por: Jennifer Xiao, et al.
Publicado: (2021)

Bones, breasts, and bisphosphonates: rationale for the use of zoledronic acid in advanced and early breast cancer
por: Allan Lipton
Publicado: (2011)

Breast cancer in Brazil: epidemiology and treatment challenges
por: Cecilio AP, et al.
Publicado: (2015)

Tamoxifen for women at high risk of breast cancer
por: Nazarali SA, et al.
Publicado: (2014)

A triple negative breast cancer: what it is not!
por: Katakkar SB
Publicado: (2012)

Taxanes in the elderly patient with metastatic breast cancer
por: Yardley DA
Publicado: (2015)

Breast cancers are rare diseases—and must be treated as such
por: John M. S. Bartlett, et al.
Publicado: (2017)

Benefits of multidisciplinary teamwork in the management of breast cancer
por: Taylor C, et al.
Publicado: (2013)

Emerging targeted combinations in the management of breast cancer
por: Lee RJ, et al.
Publicado: (2013)